CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+25.59%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(+32%)
Cap. Flow
+$8.38M
Cap. Flow
% of AUM
6.73%
Top 10 Holdings %
Top 10 Hldgs %
42.82%
Holding
77
New
12
Increased
23
Reduced
17
Closed
5
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$3.51M |
| 2 |
inTEST
INTT
|
$1.63M |
| 3 |
Organon & Co
OGN
|
$1.59M |
| 4 |
Newell Brands
NWL
|
$1.52M |
| 5 |
Pfizer
PFE
|
$1.44M |
Top Sells
| 1 |
National Healthcare
NHC
|
$4.16M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$2.1M |
| 3 |
Talos Energy
TALO
|
$1.85M |
| 4 |
Edesa Biotech
EDSA
|
$1.63M |
| 5 |
DURECT Corp
DRRX
|
$1.31M |
Sector Composition
| 1 | Healthcare | 44.16% |
| 2 | Financials | 8.39% |
| 3 | Technology | 8.19% |
| 4 | Industrials | 7.86% |
| 5 | Materials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1
DELISTED
Immunogen Inc
IMGN
| $14.8M | 11.91% | 500,000 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $6.39M | 5.13% | 450,000 | – | – |
|
3
Alico
ALCO
$259M
| $6.25M | 5.02% | 215,000 | – | – |
|
4
Radiant Logistics
RLGT
$305M
| $4.58M | 3.68% | 690,000 +70,000 | +11% | +$465K |
|
5
Newmark Group
NMRK
$3.22B
| $4.38M | 3.52% | 400,000 +50,000 | +14% | +$548K |
|
6
BGC Group
BGC
$4.65B
| $4.15M | 3.34% | 575,000 -75,000 | -12% | -$542K |
|
|
7
Royalty Pharma
RPRX
$15.6B
| $3.51M | 2.82% | +125,000 | New | +$3.51M |
|
|
TGB
8
Taseko Mines
TGB
$1.03B
| $3.5M | 2.81% | 2,500,000 | – | – |
|
9
Kyndryl
KD
$7.35B
| $2.91M | 2.34% | 140,000 +40,000 | +40% | +$831K |
|
10
PagerDuty
PD
$1.54B
| $2.78M | 2.23% | 120,000 +60,000 | +100% | +$1.39M |
|
|
11
National Healthcare
NHC
$1.76B
| $2.77M | 2.23% | 30,000 -45,000 | -60% | -$4.16M |
|
|
TAST
12
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.76M | 2.22% | 350,000 | – | – |
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $2.74M | 2.21% | 824,000 +276,000 | +50% | +$919K |
|
14
Ark Restaurants
ARKR
$24.6M
| $2.6M | 2.09% | 184,607 | – | – |
|
15
Rigel Pharmaceuticals
RIGL
$697M
| $2.47M | 1.98% | 1,700,000 +200,000 | +13% | +$290K |
|
16
Preformed Line Products
PLPC
$941M
| $2.34M | 1.88% | 17,500 | – | – |
|
17
ARKO Corp
ARKO
$564M
| $2.17M | 1.75% | 610,000 +20,000 | +3% | +$71.2K |
|
18
American Superconductor
AMSC
$2.25B
| $2.17M | 1.75% | 195,000 -5,000 | -3% | -$55.7K |
|
19
Viatris
VTRS
$12.3B
| $2.17M | 1.74% | 200,000 +75,000 | +60% | +$812K |
|
|
SVC
20
Service Properties Trust
SVC
$451M
| $2.14M | 1.72% | 250,000 +100,000 | +67% | +$854K |
|
21
Freeport-McMoran
FCX
$63.7B
| $2.13M | 1.71% | 50,000 +14,000 | +39% | +$596K |
|
22
Iovance Biotherapeutics
IOVA
$807M
| $2.03M | 1.63% | 250,000 +50,000 | +25% | +$407K |
|
23
Brookline Bancorp
BRKL
$976M
| $1.96M | 1.58% | 180,000 | – | – |
|
|
24
Organon & Co
OGN
$2.45B
| $1.8M | 1.45% | 125,000 +110,000 | +733% | +$1.59M |
|
|
WBA
25
DELISTED
Walgreens Boots Alliance
WBA
| $1.7M | 1.36% | 65,000 +25,000 | +63% | +$653K |
|